Intra- and inter-cortical motor excitability in Alzheimer's disease (Q39687521)

14 September 2017

title

Intra- and inter-cortical motor excitability in Alzheimer's disease (English)

1 reference

14 September 2017

0 references

Stefan Teipel

1 reference

14 September 2017

Jacqueline Hoeppner

1 reference

14 September 2017

Martin Wegrzyn

1 reference

14 September 2017

Johannes Thome

1 reference

14 September 2017

Alexandra Bauer

1 reference

14 September 2017

Imke Oltmann

1 reference

14 September 2017

Johannes Buchmann

1 reference

14 September 2017

publication date

13 November 2011

1 reference

Journal of Neural Transmission

14 September 2017

published in

1 reference

14 September 2017

volume

119

1 reference

14 September 2017

1 reference

14 September 2017

page(s)

605-612

1 reference

Clinical and research methods for evaluating cortical excitability.

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Transcranial magnetic stimulation in Alzheimer disease: motor cortex excitability and cognitive severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Motor cortex excitability in Alzheimer's disease and in subcortical ischemic vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Modulation of transcallosally mediated motor inhibition in children with attention deficit hyperactivity disorder (ADHD) by medication with methylphenidate (MPH).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Interactions between inhibitory and excitatory circuits in the human motor cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Cumulative risks of developing extrapyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

When, where, and how the corpus callosum changes in MCI and AD: a multimodal MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Callosal atrophy in mild cognitive impairment and Alzheimer's disease: different effects in different stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

In vivo structural neuroanatomy of corpus callosum in Alzheimer's disease and mild cognitive impairment using different MRI techniques: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Interhemispheric inhibition of the human motor cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Motor cortex excitability in Alzheimer's disease: a transcranial magnetic stimulation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Global prevalence of dementia: a Delphi consensus study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Extrapyramidal signs and other neurologic findings in clinically diagnosed Alzheimer's disease. A community-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Transcranial magnetic stimulation and the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Impaired transcallosally mediated motor inhibition in adults with attention-deficit/hyperactivity disorder is modulated by methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Demyelination and axonal degeneration in corpus callosum assessed by analysis of transcallosally mediated inhibition in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Evaluation of the size and area of the corpus callosum with the Osiris method in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

The relationship between motor cortex excitability and severity of Alzheimer's disease: a transcranial magnetic stimulation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Modification of motor cortical excitability by an acetylcholinesterase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Corticocortical inhibition in human motor cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Vascular and degenerative processes differentially affect regional interhemispheric connections in normal aging, mild cognitive impairment, and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Motor cortex disinhibition in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Alzheimer's disease: clinical trials and drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

L-dopa modulates motor cortex excitability in Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Inhibitory and excitatory interhemispheric transfers between motor cortical areas in normal humans and patients with abnormalities of the corpus callosum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Topography of fibers in the human corpus callosum mediating interhemispheric inhibition between the motor cortices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Motor cortex inhibitory circuits in dementia with Lewy bodies and in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Cortical excitability in very mild Alzheimer's disease: a long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

The assessment and analysis of handedness: The Edinburgh inventory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Motor cortex inhibition is not impaired in patients with Alzheimer's disease: evidence from paired transcranial magnetic stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Different TMS patterns of intracortical inhibition in early onset Alzheimer dementia and frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Clock-drawing: is it the ideal cognitive screening test?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Region-specific corpus callosum atrophy correlates with the regional pattern of cortical glucose metabolism in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Progression of corpus callosum atrophy in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer's disease in relation to dementia severity: evidence for early neocortical degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Human motor evoked responses to paired transcranial magnetic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Measurements of transcallosally mediated cortical inhibition for differentiating parkinsonian syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Comparison of the pattern of atrophy of the corpus callosum in frontotemporal dementia, progressive supranuclear palsy, and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0738-Y

Clinical applications of motor evoked potentials

21 January 2018

1 reference

12 December 2020

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease

1 reference

12 December 2020

Sensorimotor network rewiring in mild cognitive impairment and Alzheimer's disease.

1 reference

12 December 2020

[Alzheimer's disease and vascular dementia. Determination of atrophy of the corpus callosum and cerebral cortex].

1 reference

12 December 2020

Topography of the human corpus callosum

1 reference

12 December 2020

Dysfunction of transcallosally mediated motor inhibition and callosal morphology in patients with schizophrenia

1 reference

12 December 2020

10.1007/S00702-011-0738-Y

Identifiers

DOI

1 reference

14 September 2017

1 reference